Everest Organics

Market Cap: Micro Cap
Industry: Pharmaceuticals & Biotechnology
ISIN: INE334C01029
NSEID:
BSEID: 524790

INR

452.00

-9.95 (-2.15%)

BSENSE

Dec 19

BSE+NSE Vol: 1.42 k

{
  "main_header": {
    "sid": 160546,
    "name": "Everest Organics",
    "stock_name": "Everest Organics",
    "full_name": "Everest Organics Ltd",
    "name_url": "stocks-analysis/everest-organics",
    "exchange": 0,
    "exchangecode": "",
    "country_id": 34,
    "currency": "INR",
    "cmp": "452.00",
    "chg": -9.95,
    "chgp": "-2.15%",
    "dir": -1,
    "prev_price": "461.95",
    "mcapval": "468.00 Cr",
    "mcap": "Micro Cap",
    "scripcode": 524790,
    "symbol": "",
    "ind_name": "Pharmaceuticals & Biotechnology",
    "ind_code": 4,
    "indexname": "",
    "isin": "INE334C01029",
    "curr_date": "Dec 19",
    "curr_time": "",
    "bse_nse_vol": "1.42 k",
    "exc_status": "Active",
    "traded_date": "Dec 19, 2025",
    "traded_date_str": "2025 12 19",
    "score": "",
    "scoreText": "",
    "Live": 0,
    "market_time": 0,
    "is_blur": 1,
    "is_blur_class": "blur-registerF-score-header",
    "is_blur_url": "https://www.marketsmojo.com/mojofeed/register?redirect=/stocks-analysis/everest-organics-160546-0&utm_source=Spage_Header_Score",
    "mojoone": {
      "ismore": 0
    }
  },
  "news": {
    "results": [
      {
        "title": "Everest Organics Hits New 52-Week High at Rs.499 Mark",
        "link": "https://www.marketsmojo.com/news/stocks-in-action/everest-organics-hits-new-52-week-high-of-rs499-marking-significant-rally-3757319",
        "imagepath": "https://i.marketsmojo.com/newsimg/2025/12/EverestOrganics_priceRelatedfactors_3757319.png",
        "date": "2025-12-12 10:15:05",
        "description": "Everest Organics, a key player in the Pharmaceuticals & Biotechnology sector, has reached a significant milestone by touching a new 52-week high of Rs.499. This achievement marks a notable phase in the stock’s performance, reflecting sustained momentum over recent trading sessions."
      },
      {
        "title": "Everest Organics Stock Hits All-Time High at Rs.499",
        "link": "https://www.marketsmojo.com/news/stocks-in-action/everest-organics-stock-hits-all-time-high-at-rs499-marking-a-significant-milestone-3757193",
        "imagepath": "https://i.marketsmojo.com/newsimg/2025/12/EverestOrganics_priceRelatedfactors_3757193.png",
        "date": "2025-12-12 09:31:17",
        "description": "Everest Organics, a key player in the Pharmaceuticals & Biotechnology sector, reached a new all-time high of Rs.499 today, marking a significant milestone in its market journey. The stock’s performance over recent periods highlights a robust trajectory that has outpaced broader market indices and sector benchmarks."
      },
      {
        "title": "Everest Organics Hits New 52-Week High of Rs.490, Marking Significant Milestone",
        "link": "https://www.marketsmojo.com/news/stocks-in-action/everest-organics-hits-new-52-week-high-at-rs490-marking-significant-rally-3753865",
        "imagepath": "https://i.marketsmojo.com/newsimg/2025/12/EverestOrganics_priceRelatedfactors_3753865.png",
        "date": "2025-12-09 11:45:06",
        "description": "Everest Organics has reached a new 52-week high, touching Rs.490 today, reflecting a notable surge in its stock price and marking a key milestone for the Pharmaceuticals & Biotechnology company. This achievement underscores the stock’s strong momentum amid a volatile trading session."
      },
      {
        "title": "Everest Organics Hits All-Time High at Rs.490, Marking a Significant Milestone",
        "link": "https://www.marketsmojo.com/news/stocks-in-action/everest-organics-stock-hits-all-time-high-at-rs490-marking-a-significant-milestone-3753756",
        "imagepath": "https://i.marketsmojo.com/newsimg/2025/12/EverestOrganics_priceRelatedfactors_3753756.png",
        "date": "2025-12-09 11:03:38",
        "description": "Everest Organics, a key player in the Pharmaceuticals & Biotechnology sector, reached a new all-time high of Rs.490 today, reflecting a notable phase in its market journey. This milestone underscores the company’s sustained performance amid a volatile trading session and highlights its position relative to broader market indices."
      },
      {
        "title": "Why is Everest Organics falling/rising?",
        "link": "https://www.marketsmojo.com/news/stocks-in-action/why-is-everest-organics-fallingrising-3752161",
        "imagepath": "",
        "date": "2025-12-09 00:31:38",
        "description": "    <div class=\"article-news-new\">\n        <div class=\"article-container\">\n\n<div class=\"article-content\">\n\n<p><strong>Strong Price Performance Against Benchmarks</strong></p>\n<p>Everest Organics has demonstrated exceptional returns over multiple time horizons compared to the Sensex. Over the past week, the stock surged 8.27%, while the Sensex declined by 0.63%. The one-month gain of 11.82% further eclipses the Sensex’s 2.27% rise. Year-to-date, Everest Organics has delivered a remarkable 52.13% return, vastly outperforming the Sensex’s 8.91%. Even more striking is the one-year return of 212.63%, dwarfing the Sensex’s modest 4.15% gain. Over three years, the stock has appreciated by 257.67%, compared to the Sensex’s 36.01%, underscoring its sustained growth trajectory despite broader market fluctuations.</p>\n<p><strong>Intraday Volatility and Trading Range</strong></p>\n<p>On 08-Dec, Everest Organics traded w..."
      },
      {
        "title": "Is Everest Organics overvalued or undervalued?",
        "link": "https://www.marketsmojo.com/news/stocks-in-action/is-everest-organics-overvalued-or-undervalued-3747555",
        "imagepath": "",
        "date": "2025-12-05 08:18:49",
        "description": "    <div class=\"article-news-new\">\n        <div class=\"article-container\">\n\n<div class=\"article-content\">\n\n<p><strong>Valuation Metrics Indicate Premium Pricing</strong></p>\n<p>Everest Organics currently trades at a price-to-earnings (PE) ratio exceeding 60, significantly higher than many of its pharmaceutical peers. This elevated PE ratio suggests that the market is pricing in substantial future earnings growth. The price-to-book value stands above 5.5, reinforcing the notion of a premium valuation relative to the company's net assets.</p>\n<p>Enterprise value multiples also reflect this premium stance. The EV to EBIT ratio is over 40, and EV to EBITDA is close to 27, both considerably above industry averages. These multiples indicate that investors are willing to pay a hefty premium for the company's earnings before interest, taxes, depreciation, and amortisation, signalling strong confidence in Everest Or..."
      },
      {
        "title": "Everest Organics Sees Revised Market Assessment Amid Mixed Financial Signals",
        "link": "https://www.marketsmojo.com/news/stock-recommendation/everest-organics-upgraded-from-sell-to-hold-by-marketsmojo-on-20-june-2025-3741382",
        "imagepath": "https://i.marketsmojo.com/newsimg/2025/12/EverestOrganics_mojoScore_3741382.png",
        "date": "2025-12-02 10:09:05",
        "description": "Everest Organics, a microcap player in the Pharmaceuticals & Biotechnology sector, has experienced a revision in its market evaluation reflecting a nuanced shift in its financial and technical outlook. This change comes amid a backdrop of mixed fundamental indicators and notable stock performance over the past year."
      },
      {
        "title": "Everest Organics Faces Intense Selling Pressure Amid Consecutive Losses",
        "link": "https://www.marketsmojo.com/news/stocks-in-action/everest-organics-faces-intense-selling-pressure-amid-lower-circuit-lockdown-3725439",
        "imagepath": "https://i.marketsmojo.com/newsimg/2025/11/EverestOrganics_only_sellers_3725439.png",
        "date": "2025-11-24 12:10:10",
        "description": "Everest Organics Ltd has encountered significant selling pressure on 24 Nov 2025, with the stock registering a sharp decline and exhibiting a complete absence of buyers. The pharmaceutical and biotechnology company’s shares have fallen consecutively over the past two sessions, signalling distress selling and heightened market caution."
      },
      {
        "title": "Everest Organics Faces Intense Selling Pressure Amid Lower Circuit Lockdown",
        "link": "https://www.marketsmojo.com/news/stocks-in-action/everest-organics-faces-severe-selling-pressure-hits-lower-circuit-amid-distress-signals-3721095",
        "imagepath": "https://i.marketsmojo.com/newsimg/2025/11/EverestOrganics_only_sellers_3721095.png",
        "date": "2025-11-21 13:40:09",
        "description": "Everest Organics Ltd experienced a pronounced sell-off on 21 Nov 2025, with the stock hitting its lower circuit and registering only sell orders in the queue. This extreme selling pressure signals distress among investors, as the pharmaceutical and biotechnology company’s shares declined sharply, diverging notably from broader market trends."
      }
    ],
    "total": 313,
    "sid": "160546",
    "stock_news_url": "https://www.marketsmojo.com/news/everest-organics-160546"
  },
  "announcements": [
    {
      "caption": "Shareholder Meeting / Postal Ballot-Outcome of Postal_Ballot",
      "datetime": "17-Dec-2025",
      "details": "Submission of voting results for the postal ballot (E voting).",
      "source": "BSE"
    },
    {
      "caption": "Intimation Of Newspaper Publication With Respect To Special Window For Re-Lodgement Of Physical Share Transfer Requests",
      "datetime": "17-Dec-2025",
      "details": "Newspaper Advertisement.",
      "source": "BSE"
    },
    {
      "caption": "Shareholder Meeting / Postal Ballot-Scrutinizers Report",
      "datetime": "17-Dec-2025",
      "details": "Scrutinizer s Report",
      "source": "BSE"
    }
  ],
  "corporate_actions": [
    {
      "img": "board-meeting.svg",
      "title": "BOARD MEETING",
      "msg": "<span>No</span> Upcoming Board Meetings",
      "data": []
    },
    {
      "img": "dividend.svg",
      "title": "DIVIDEND",
      "msg": "",
      "data": [
        {
          "txt": "Everest Organics Ltd has declared <strong>5%</strong> dividend, ex-date: 15 Sep 22",
          "dt": "2022-09-15",
          "middle_text": "Dividend Alert"
        }
      ]
    },
    {
      "img": "splits.svg",
      "title": "SPLITS",
      "msg": "No <strong>Splits</strong> history available",
      "data": []
    },
    {
      "img": "bonus.svg",
      "title": "BONUS",
      "msg": "No <strong>Bonus</strong> history available",
      "data": []
    },
    {
      "img": "rights-issues.svg",
      "title": "RIGHTS",
      "msg": "No <strong>Rights</strong> history available",
      "data": []
    }
  ]
}

News and Views

Everest Organics Hits New 52-Week High at Rs.499 Mark

2025-12-12 10:15:05

Everest Organics, a key player in the Pharmaceuticals & Biotechnology sector, has reached a significant milestone by touching a new 52-week high of Rs.499. This achievement marks a notable phase in the stock’s performance, reflecting sustained momentum over recent trading sessions.

Everest Organics Stock Hits All-Time High at Rs.499

2025-12-12 09:31:17

Everest Organics, a key player in the Pharmaceuticals & Biotechnology sector, reached a new all-time high of Rs.499 today, marking a significant milestone in its market journey. The stock’s performance over recent periods highlights a robust trajectory that has outpaced broader market indices and sector benchmarks.

Everest Organics Hits New 52-Week High of Rs.490, Marking Significant Milestone

2025-12-09 11:45:06

Everest Organics has reached a new 52-week high, touching Rs.490 today, reflecting a notable surge in its stock price and marking a key milestone for the Pharmaceuticals & Biotechnology company. This achievement underscores the stock’s strong momentum amid a volatile trading session.

Everest Organics Hits All-Time High at Rs.490, Marking a Significant Milestone

2025-12-09 11:03:38

Everest Organics, a key player in the Pharmaceuticals & Biotechnology sector, reached a new all-time high of Rs.490 today, reflecting a notable phase in its market journey. This milestone underscores the company’s sustained performance amid a volatile trading session and highlights its position relative to broader market indices.

Why is Everest Organics falling/rising?

2025-12-09 00:31:38

Strong Price Performance Against Benchmarks

Everest Organics has demonstrated exceptional returns over multiple time horizons compared to the Sensex. Over the past week, the stock surged 8.27%, while the Sensex declined by 0.63%. The one-month gain of 11.82% further eclipses the Sensex’s 2.27% rise. Year-to-date, Everest Organics has delivered a remarkable 52.13% return, vastly outperforming the Sensex’s 8.91%. Even more striking is the one-year return of 212.63%, dwarfing the Sensex’s modest 4.15% gain. Over three years, the stock has appreciated by 257.67%, compared to the Sensex’s 36.01%, underscoring its sustained growth trajectory despite broader market fluctuations.

Intraday Volatility and Trading Range

On 08-Dec, Everest Organics traded w...

Is Everest Organics overvalued or undervalued?

2025-12-05 08:18:49

Valuation Metrics Indicate Premium Pricing

Everest Organics currently trades at a price-to-earnings (PE) ratio exceeding 60, significantly higher than many of its pharmaceutical peers. This elevated PE ratio suggests that the market is pricing in substantial future earnings growth. The price-to-book value stands above 5.5, reinforcing the notion of a premium valuation relative to the company's net assets.

Enterprise value multiples also reflect this premium stance. The EV to EBIT ratio is over 40, and EV to EBITDA is close to 27, both considerably above industry averages. These multiples indicate that investors are willing to pay a hefty premium for the company's earnings before interest, taxes, depreciation, and amortisation, signalling strong confidence in Everest Or...

Everest Organics Sees Revised Market Assessment Amid Mixed Financial Signals

2025-12-02 10:09:05

Everest Organics, a microcap player in the Pharmaceuticals & Biotechnology sector, has experienced a revision in its market evaluation reflecting a nuanced shift in its financial and technical outlook. This change comes amid a backdrop of mixed fundamental indicators and notable stock performance over the past year.

Everest Organics Faces Intense Selling Pressure Amid Consecutive Losses

2025-11-24 12:10:10

Everest Organics Ltd has encountered significant selling pressure on 24 Nov 2025, with the stock registering a sharp decline and exhibiting a complete absence of buyers. The pharmaceutical and biotechnology company’s shares have fallen consecutively over the past two sessions, signalling distress selling and heightened market caution.

Everest Organics Faces Intense Selling Pressure Amid Lower Circuit Lockdown

2025-11-21 13:40:09

Everest Organics Ltd experienced a pronounced sell-off on 21 Nov 2025, with the stock hitting its lower circuit and registering only sell orders in the queue. This extreme selling pressure signals distress among investors, as the pharmaceutical and biotechnology company’s shares declined sharply, diverging notably from broader market trends.